CSPC Pharmaceutical Group Ltd.

Company Snapshot

Founded: 1992
Entity Type: Public
Employees: 21,400
Region: China
Revenue: $4,031.3 Millions
Revenue Year: 2024
Headquarter: Hong Kong, China
Key Geographics: North America, Europe, Mainland China, Other Asia
Corporate Address: No.896 Zhongshandong Street, Gaoxin District, Shijiazhuang, Hebei Province, 050035, People Republic of China Tel. +(86)-311-8703-7015 www.cspc.com

Company Overview

CSPC Pharmaceutical Group Limited is one of the prominent pharmaceutical companies in China, developing innovative drugs, generics, and APIs. Formed in 1992 in Shijiazhuang, Hebei, China, this firm operates worldwide, mainly focusing on research and development, manufacturing, and commercialization.

The company operates through numerous subsidiaries and portfolio lines: oncology, cardiovascular, anti-infectives, and central nervous system therapy lines. CSPC employs approximately 21,400 people and continues to expand its presence in domestic and international markets through innovation and strategic partnerships.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

CSPC Pharmaceutical Group Ltd. In Reports

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

BCC Research Report: Dive into pharmaceutical drugs market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

BCC Research Market Report for Chronic Disease Management. Global Chronic Disease Management market trends, with CAGRs through 2026.

Active Pharmaceutical Ingredients: Global Markets

BCC market research report for global active pharmaceutical ingredients (API) market. Estimation of the market size and analyses of market trends, with data from 2019, estimates for 2020 and projection of CAGR through...

Company's Business Segments

  • Finished Drugs : It includes research and development, manufacture and sale of pharmaceutical products, and licence fees income.
  • Bulk Products : It includes the manufacturing and sales of vitamin C and antibiotic products in bulk powder forms.
  • Functional Foods and Others : It includes the manufacturing and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose, and vitamin C buccal tablets), as well as the provision of healthcare services and other related activities.

Applications/End User Industries

  • Medical
  • Healthcare
AI Sentiment